GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER

  • Authors:
    • V SCHIRRMACHER
    • U ZANGEMEISTERWITTKE
  • View Affiliations

  • Published online on: February 1, 1994     https://doi.org/10.3892/ijo.4.2.335
  • Pages: 335-346
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Using a metastasizing animal tumor as a model we describe experimental conditions for obtaining either synergistic or antagonistic effects between host irradiation and T cell mediated antitumor immunity. The results were obtained in the well defined murine lymphoma ESb which is a spontaneous highly metastatic tumor variant expressing a tumor associated antigen that can induce protective immunity and tumor specific cytotoxic T lymphocyte (CTL) activity. Sublethal irradiation of mice during the afferent (induction) phase but not during the efferent (effector) phase of the antitumor immune response had a strong suppressive effect on protective immunity. The radiation mediated defect could be reconstituted by transfer of immune spleen cells. The immune system of syngeneic (DBA/2) and allogeneic (B10.D2) mice changed within 24 h after first contact with the ESb tumor cells from radio-sensitivity to radio-resistance possibly reflecting an active cellular response associated with the change from virgin to an antigen sensitized (primed) state of T lymphocyte differentiation. T cell depletion experiments revealed that the afferent phase was dependent on both CD4 and CD8 host T lymphocytes while the efferent phase was mainly CD8 T cell dependent. A synergistic effect between gamma-irradiation and antitumor immunity was observed in adoptive immunotherapy experiments. When tumor-bearing hosts were irradiated before intravenous transfer of either syngeneic or allogeneic antitumor immune T cells the expression of anti-metastatic protective immunity was greatly enhanced in comparison to identically treated non-irradiated hosts.

Related Articles

Journal Cover

February 1994
Volume 4 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
SCHIRRMACHER V and SCHIRRMACHER V: GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER. Int J Oncol 4: 335-346, 1994
APA
SCHIRRMACHER, V., & SCHIRRMACHER, V. (1994). GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER. International Journal of Oncology, 4, 335-346. https://doi.org/10.3892/ijo.4.2.335
MLA
SCHIRRMACHER, V., ZANGEMEISTERWITTKE, U."GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER". International Journal of Oncology 4.2 (1994): 335-346.
Chicago
SCHIRRMACHER, V., ZANGEMEISTERWITTKE, U."GAMMA-IRRADIATION SUPPRESSES T-CELL MEDIATED PROTECTIVE IMMUNITY AGAINST A METASTATIC TUMOR IN THE AFFERENT PHASE OF THE IMMUNE-RESPONSE BUT ENHANCES IT IN THE EFFERENT PHASE WHEN GIVEN BEFORE IMMUNE CELL TRANSFER". International Journal of Oncology 4, no. 2 (1994): 335-346. https://doi.org/10.3892/ijo.4.2.335